NYSE · AVD

American Vanguard Corporation

$2.62 +$0.05 (+1.75%) 1D Market open

Key Metrics

$73.52M
Market cap
P/E · TTM
$522.88M
Revenue · TTM
−$45.57M
Net income
EPS · TTM $-1.61
Dividend yield
Free cash flow
Beta · 1Y 0.92
EBITDA · TTM −$16.86M
Gross margin 29.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 30
    The stock moved +22.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 30
  • Mar 27
    From its Feb 19 high, the share price fell 62%.

    Peak close $5.41 on Feb 19; trough close $2.06 on Mar 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -62%
  • Mar 17
    The stock moved -14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$73.52M
Enterprise value
Shares outstanding28.6M
52-wk range$2.05 – $5.92
Avg volume · 20D230.8K
Net cash
Book value / share$6.71
IndustryAgricultural Chemicals
ExchangeNYSE
About American Vanguard Corporation
IPO dateMar 3, 1987
Employees739

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.14
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 29.8%
Operating -4.2%
Net -8.7%
FCF
ROE / ROIC -24.0% · —

Financial Health

Current ratio2.32
Quick ratio1.41
Debt / equity1.41
Debt / EBITDA -15.81
Net cash
Working capital$252.63M

Cash Flow · TTM

Operating CF −$36.06M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

1.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings